Your browser doesn't support javascript.
loading
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply.
Clarke, Robert J; Aung, Theingi; Armitage, Jane.
Affiliation
  • Clarke RJ; Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England.
  • Aung T; Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England.
  • Armitage J; Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England.
JAMA Cardiol ; 3(8): 781-782, 2018 08 01.
Article in En | MEDLINE | ID: mdl-29874365
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Fatty Acids, Omega-3 Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Cardiol Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Fatty Acids, Omega-3 Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Cardiol Year: 2018 Document type: Article Affiliation country: Country of publication: